Hikma Pharmaceutical | HIK - Capital Y Las Reservas





Capital Y Las Reservas Cambio Fecha
Almirall EUR 1.49B 24.03M 2025-12
argenx SE USD 7.32B 1.23B 2025-12
AstraZeneca USD 47.33B 1.33B 2026-03
Autolus Therapeutics Ltd USD 108.83M 69.3M 2026-03
Bayer EUR 28.85B 2.9B 2026-03
Fresenius EUR 19.77B 1.14B 2025-12
Genmab DKK 5.85B 96M 2025-12
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
GRIFOLS EUR 5.46B 171M 2026-03
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Lakefront Biotherapeutics EUR 3.25B 17.5M 2026-03
Lonza CHF 9.13B 513M 2025-12
Merck EUR 29.74B 1.15B 2026-03
Orion EUR 1.12B 162.1M 2026-03
Recordati EUR 2.06B 140.52M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 72.81B 1.1B 2026-03
UCB EUR 10.87B 1.18B 2025-12